Table 4 Secondary outcome in CPAP device usage.

From: The efficiency of azelastine hydrochloride and fluticasone propionate nasal spray to improve PAP adherence in patients with obstructive sleep apnea

Variables

Intervention

(N = 54)

Placebo

(N = 53)

P value

Leakage (L/min)

24.6(14.4, 40.8)

24(9.6, 39.6)

0.53

% day usage

69.99 ± 29.68

69.99 ± 31.69

0.64

Total day usage

29.90 ± 1.05

30.90 ± 0.70

0.43

Average daily usage (Hr)

3.5 (1.35, 5.47)

3.33(1.41, 5.26)

0.92

  1. Data shown as mean ± SD or median (interquartile range).
  2. Leakage = 95th percentile leakage, L/min = liter per minute, %day usage =, the percentage number of days the CPAP device was used, averagedailyusage (Hr) = the number of hours per day the device was used (hour/day).
Back to article page